Made right here: Five ways The Royal is transforming mental illness and addiction care in Canada

False

Care and research at The Royal doesn't just serve Canadians; it contributes to better care around the world.

At The Royal, our teams have delivered many Canadian firsts in care, treatment, and research, and we continue to lead in areas where progress is urgently needed.

This work does not happen in isolation. It's made possible by decades of persistence to drive innovation and change.

Every breakthrough, every Canadian first, brings us closer to the goal of reclaiming lives from mental illness and addiction.

Here are five ways The Royal shapes mental illness and addiction care in Canada.

First in Canada: Stellate Ganglion Block as a treatment for PTSD

The Royal is evaluating a promising treatment for post-traumatic stress disorder called Stellate Ganglion Block (SGB).

Our research is a Canadian first. Informed by the lived experience of veterans and backed by donor funding, participants are now being recruited from across the country.

First in Canada: Ground-breaking brain imaging

The Royal is leading the nation with the creation of a revolutionary brain imaging research platform—the first of its kind in Canada—setting a new standard in mental illness care and discovery. This cutting-edge platform gives researchers an unprecedented, integrated view of the brain. This leap forward in brain science will drive earlier diagnoses, more precise treatments, and better outcomes for people living with mental illness.